D-dimer Levels in Pregnant With COVID-19

Assessment of D-dimer Levels in Pregnant Women Diagnosed With COVID-19

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04389554

Enrollment

300

Registered

2020-05-15

Start date

2020-05-14

Completion date

2020-05-29

Last updated

2020-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, D-dimer

Keywords

pregnancy, COVID-19, D-dimer

Brief summary

D-dimer measurements act as a global indicator of coagulation and activation of fibrinolytic systems. An optimal cut-off value for D-dimer and its effect on prognosis has not yet been assessed to predict mortality in admission. Therefore, studies comparing D-dimer values of COVID-19 patients and healthy pregnant women are needed. Our study gives us the opportunity to make this comparison.

Interventions

OTHERBlood D-dimer assay

Blood samples will be taken from the patients and will be examined by the ELISA method.

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 45 Years

Inclusion criteria

* Pregnant women with COVID-19

Exclusion criteria

\- Having a chronic disease that raises D-dimer levels

Design outcomes

Primary

Measure	Time frame
Compare D-dimer values of COVID-19 patients and healthy pregnant women	one day

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026